The 6L9.F stock surged intraday on 11 Mar 2026 after a sharp volume spike, trading at €0.025 versus yesterday’s close €0.001. This move represented a +2400.00% change and pushed volume to 3,500 shares, roughly 12.54x the average daily volume. On XETRA in Germany, the move stands out in the Healthcare sector because ViewRay, Inc. (6L9.F) still shows long-term weakness versus its 50-day average €0.319 and 200-day average €2.717. We examine drivers, fundamentals, and risk for short-term traders and longer-term investors.
Intraday high-volume mover: what traded
One clear fact: 6L9.F stock moved on volume, not broad sector strength. Volume reached 3,500 vs average 279, giving a relative volume of 12.54. The intraday range was €0.001 to €0.025, with the jump tied to thin liquidity and wide bid-ask bands on XETRA. Market-cap sits near €207,228,256 and shares outstanding are 8,289,130,240, so even small trade blocks move price materially.
Company snapshot and market context
ViewRay, Inc. (6L9.F) designs MRI-guided radiation therapy systems and lists on XETRA while operating primarily in the United States. Revenue per share TTM is 0.566, EPS is -0.55, and the company reports a book value per share of 0.455. The Healthcare sector on XETRA is stable year-to-date, but ViewRay’s year high €4.600 and low €0.0005 show extreme volatility and capital structure stresses relative to peers.
Fundamental picture: key ratios and signals
Fundamentals show mixed signals: price-to-sales TTM 2.35, price-to-book 0.06, current ratio 2.36, and debt-to-equity 1.05. Profitability remains negative with ROE -85.17% and operating margin deeply negative. Cash per share 0.752 gives some runway, but operating cash flow per share is -0.508, highlighting ongoing cash burn. These metrics explain why volatility can trigger outsized percentage moves in low-priced names.
Technical and trading indicators for traders
Technically, 6L9.F is extremely volatile and illiquid on XETRA; the 50-day average €0.319 and 200-day average €2.717 are far above the current price €0.025. Short-term traders should watch intraday support near €0.001 and resistance at the day high €0.025. The stock’s relVolume of 12.54 signals a one-off liquidity event rather than steady accumulation, increasing the probability of rapid reversals.
Meyka AI grade and analyst framing
Meyka AI rates 6L9.F with a score of 61.54 out of 100 — Grade B | HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst signals. The grade reflects recovery potential from valuation extremes but also flags operating losses and thin liquidity. Remember, grades are informational and not financial advice.
Risks, catalysts and what to watch next
Immediate risks include extreme bid-ask spreads, continued low liquidity, and ongoing negative operating cash flow. Catalysts that could move price sustainably include tender offers, asset sales, product contracts, or corporate news from ViewRay. Watch regulatory or clinical updates for MRIdian systems and any filings that change share count or cash runway.
Final Thoughts
Key takeaways for 6L9.F stock: today’s intraday +2400.00% move on XETRA was driven by thin liquidity and a 3,500 share volume spike, not by a visible improvement in core fundamentals. ViewRay, Inc. shows negative EPS -0.55, a low price-to-book 0.06, and working capital strength with cash per share 0.752, but operating cash flow remains negative. Meyka AI’s forecast model projects a 12-month base case target of €0.10, implying an upside of +300.00% from the current €0.025. We present a conservative range: bear €0.01, base €0.10, bull €0.50. These figures are model-based projections and not guarantees. Traders focused on high-volume movers should size positions carefully, monitor spreads on XETRA, and track company announcements via the ViewRay site ViewRay and our stock hub Meyka 6L9.F page. Meyka AI is an AI-powered market analysis platform providing real-time signals and grades to support investor research.
FAQs
What drove the intraday surge in 6L9.F stock on 11 Mar 2026?
The move appears driven by thin liquidity and a concentrated trade block. Volume jumped to 3,500 from an average 279, producing a +2400.00% change. No public earnings or regulatory news matched the spike on XETRA.
How does Meyka AI assess 6L9.F stock now?
Meyka AI rates 6L9.F 61.54/100 (Grade B, HOLD). The grade factors sector comparison, financial metrics, growth prospects, and analyst signals. This is informational and not investment advice.
What is the short-term outlook and price forecast for 6L9.F stock?
Short-term outlook remains volatile due to low liquidity and negative cash flow. Meyka AI’s model projects a 12-month base target of €0.10, implying +300.00% from €0.025. Forecasts are projections, not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)